Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Jan. 31, 2019. Julie Khani.

Executive Summary

Sen. Chuck Grassley cites a US Government Accountability Office analysis in arguing the Medicare agency may be preparing to overpay clinical labs, but the lab industry says GAO is misguided. See what the American Clinical Laboratory Association's Julie Khani has to say about it here.

“GAO concocts a hypothetical scenario that suggests labs are unbundling these tests and receiving higher reimbursement – this is grossly inaccurate.” – Julie Khani, president, American Clinical Laboratory Association

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124568

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel